BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32682310)

  • 1. Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil.
    do Vale Moreira NC; Hussain A; Bhowmik B; Mdala I; Siddiquee T; Fernandes VO; Montenegro Júnior RM; Meyer HE
    Diabetes Metab Syndr; 2020; 14(5):1217-1224. PubMed ID: 32682310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
    Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome in elderly and agreement among four diagnostic criteria.
    Saad MA; Cardoso GP; Martins Wde A; Velarde LG; Cruz Filho RA
    Arq Bras Cardiol; 2014 Mar; 102(3):263-9. PubMed ID: 24676226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions.
    Bhowmik B; Afsana F; Siddiquee T; Munir SB; Sheikh F; Wright E; Bhuiyan FR; Ashrafuzzaman SM; Mahtab H; Azad Khan AK; Hussain A
    J Diabetes Investig; 2015 May; 6(3):280-8. PubMed ID: 25969712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
    Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
    Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Prevalence of Metabolic Syndrome According to Different Definitions in Climacteric Women.
    Chaves Pereira Reis VM; Santos Brant Rocha J; Fonseca AA; Ferreira Freitas R; Araújo Passos BM; Perim Baldo M; Silveira Freire R; Chaves Veloso Reis G; Piana Santo Lima de Oliveira F; Almeida de Magalhães T; Fagundes Silveira M
    Metab Syndr Relat Disord; 2021 Oct; 19(8):436-442. PubMed ID: 34227853
    [No Abstract]   [Full Text] [Related]  

  • 7. All-cause and cardiovascular mortality risk estimation using different definitions of metabolic syndrome in Lithuanian urban population.
    Luksiene D; Baceviciene M; Jureniene K; Bernotiene G; Reklaitiene R; Radisauskas R; Tamosiunas A
    Prev Med; 2012 Oct; 55(4):299-304. PubMed ID: 23046635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Three Diagnostic Definitions of Metabolic Syndrome and Estimation of Its Prevalence in Mongolia.
    Myagmar-Ochir E; Haruyama Y; Takaoka N; Takahashi K; Dashdorj N; Dashtseren M; Kobashi G
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
    Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran: a comparative analysis of six definitions.
    Esmailzadehha N; Ziaee A; Kazemifar AM; Ghorbani A; Oveisi S
    Endocr Regul; 2013 Jul; 47(3):111-20. PubMed ID: 23889480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR Study.
    Mannucci E; Monami M; Bardini G; Ognibene A; Rotella CM
    J Endocrinol Invest; 2007 Dec; 30(11):925-30. PubMed ID: 18250613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study.
    Gronner MF; Bosi PL; Carvalho AM; Casale G; Contrera D; Pereira MA; Diogo TM; Torquato MT; Souza GM; Oishi J; Leal AM
    Braz J Med Biol Res; 2011 Jul; 44(7):713-9. PubMed ID: 21755260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
    Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
    Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in Japanese-Brazilians according to specific definitions for ethnicity.
    Xavier NP; Chaim RC; Gimeno SG; Ferreira SR; Hirai AT; Padovani CR; Okoshi MP; Okoshi K
    Metab Syndr Relat Disord; 2010 Apr; 8(2):143-8. PubMed ID: 19900161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.
    Wand H; Calmy A; Carey DL; Samaras K; Carr A; Law MG; Cooper DA; Emery S;
    AIDS; 2007 Nov; 21(18):2445-53. PubMed ID: 18025881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].
    Rodríguez Bernardino A; García Polavieja P; Reviriego Fernández J; Serrano Ríos M
    Endocrinol Nutr; 2010 Feb; 57(2):60-70. PubMed ID: 20153706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults.
    Nascimento-Ferreira MV; Rendo-Urteaga T; Vilanova-Campelo RC; Carvalho HB; da Paz Oliveira G; Paes Landim MB; Torres-Leal FL
    Clin Nutr; 2017 Dec; 36(6):1693-1700. PubMed ID: 28081980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.